Suppr超能文献

2'-C-甲基-6-O-甲基鸟苷核苷和 L-丙氨酸酯磷酰胺的 7-脱氮类似物的合成及抗丙型肝炎病毒活性评价。

Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2'-C-methyl-6-O-methyl guanosine nucleoside and L-Alanine ester phosphoramidates.

机构信息

School of Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK.

出版信息

Bioorg Med Chem Lett. 2013 Apr 1;23(7):2260-4. doi: 10.1016/j.bmcl.2012.12.004. Epub 2012 Dec 20.

Abstract

7-Deazapurines are known to possess broad antiviral activity, however the 2'-C-methylguanosine analogue displays poor cell permeation and limited phosphorylation, thus is not an efficient inhibitor of hepatitis C virus (HCV) replication. We previously reported the 6-O-methyl entity as a prodrug moiety to increase liphophilicity of guanine nucleosides and the ProTide approach applied to 2'-C-methyl-6-O-methylguanosine has lead to potent HCV inhibitors now in clinical trials. In this Letter, we report the synthesis and biological evaluation of 2'-C-methyl-6-O-methyl-7-deaza guanosine and ProTide derivatives. In contrast to prior studies, removal of the N-7 of the nucleobase entirely negates anti-HCV activity compared to the 2'-C-methyl-6-O-methylguanosine analogues. To understand better this significant loss of activity, enzymatic assays and molecular modeling were carried out and suggested 2'-C-methyl-6-O-methyl-7-deaza guanosine and related ProTides do not act as efficient prodrugs of the free nucleotide, in marked contrast to the case of the parent guanine analogue.

摘要

7-脱氮嘌呤具有广泛的抗病毒活性,然而,2'-C-甲基鸟苷类似物的细胞通透性差,磷酸化有限,因此不是丙型肝炎病毒(HCV)复制的有效抑制剂。我们之前报道了 6-O-甲基实体作为前药部分,以增加鸟苷核苷的亲脂性,并且将 ProTide 方法应用于 2'-C-甲基-6-O-甲基鸟苷已经导致了现在正在临床试验中的有效的 HCV 抑制剂。在这封信中,我们报告了 2'-C-甲基-6-O-甲基-7-脱氮鸟苷和 ProTide 衍生物的合成和生物学评价。与之前的研究相比,与 2'-C-甲基-6-O-甲基鸟苷类似物相比,完全去除碱基的 N-7 完全消除了抗 HCV 活性。为了更好地理解这种活性的显著丧失,进行了酶促测定和分子建模,表明 2'-C-甲基-6-O-甲基-7-脱氮鸟苷和相关的 ProTides 不作为游离核苷酸的有效前药,与母体鸟嘌呤类似物的情况形成鲜明对比。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验